Cerebellum’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$65K Sell
433
-169
-28% -$26.5K 0.3% 82
2020
Q2
$127K Buy
+602
New +$99.4K 0.09% 209
2019
Q4
$408K Hold
1,943
0.22% 314
2019
Q3
$365K Buy
1,943
+390
+25% +$76.5K 0.23% 321
2019
Q2
$310K Hold
1,553
0.25% 309
2019
Q1
$325K Buy
+1,553
New +$316K 0.28% 213
2018
Q2
Sell
-840
Closed -$147K 487
2018
Q1
$147K Sell
840
-4
-0.5% -$647 0.19% 304
2017
Q4
$127K Buy
+844
New +$130K 0.09% 209

Other funds holding MSGS

Cerebellum's MSGS Position: Q3 2020 in Review

Cerebellum reduced its Madison Square Garden (MSGS) stake by 28% in Q3 2020, selling an estimated $26.5K and leaving 433 shares worth $65K. The position accounts for 0.3% of the portfolio, ranked #82.

Cerebellum first reported a position in MSGS in Q4 2017 and has held it in 8 quarters since. The position peaked at $408K in Q4 2019. 264 funds tracked by Wall St. Rank hold MSGS as of Q3 2020.

  • Cerebellum held 433 shares of Madison Square Garden worth $65K as of Q3 2020.
  • Cerebellum sold 169 Madison Square Garden shares in Q3 2020, an estimated $26.5K.
  • Madison Square Garden made up 0.3% of Cerebellum's portfolio in Q3 2020, its #82 holding.
  • Cerebellum first reported a position in Madison Square Garden in Q4 2017 and has held it in 8 quarters since.
  • Cerebellum's Madison Square Garden position peaked at $408K in Q4 2019.
  • 264 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.